| |
| Issue |
Title |
| |
| Vol 18, No 4 (2021) |
Obesity and covid-19 — signs of convergence of two pandemiсs. Guidelines to fight obesity based on the principles of «ROOTS» |
Abstract
PDF (Rus)
|
|
A. B. Fursov, O. B. Ospanov, R. A. Fursov |
| |
| Vol 18, No 4 (2021) |
Beta-cell autophagy under the scope of hypoglycemic drugs; possible mechanism as a novel therapeutic target |
Abstract
PDF (Eng)
|
|
B. A. Marzoog, T. I. Vlasova |
| |
| Vol 18, No 4 (2021) |
A view at postbariatric hypoglycemia by endocrinologist |
Abstract
PDF (Rus)
|
|
E. I. Kim, E. V. Ershova, N. V. Mazurina, K. A. Komshilova |
| |
| Vol 18, No 4 (2021) |
Growth hormone deficiency in childhood brain tumors and acute lymphoblastic leukemia survivors |
Abstract
PDF (Rus)
|
|
M. G. Pavlova, T. Y. Tselovalnikova, A. E. Yudina, O. O. Golounina, A. V. Zilov, N. A. Mazerkina, O. G. Zheludkova, V. V. Fadeev |
| |
| Vol 18, No 4 (2021) |
Evaluation of the effectiveness of weight loss and the return of lost weight after sleeve gastrectomy in the long term follow-up period |
Abstract
PDF (Rus)
|
|
A. E. Neimark, M. A. Molotkova, E. N. Kravchuk, O. V. Kornyushimn |
| |
| Vol 18, No 3 (2021) |
Endocrine disruptors in the pathogenesis of socially significant diseases such as diabetes mellitus, malignant neoplasms, cardiovascular diseases, pathology of the reproductive system |
Abstract
PDF (Rus)
|
|
A. A. Evteeva, M. S. Sheremeta, E. A. Pigarova |
| |
| Vol 18, No 3 (2021) |
Lymphatic system and adipose tissue: Crosstalk in health and disease |
Abstract
PDF (Rus)
|
|
V. V. Klimontov, D. M. Bulumbaeva |
| |
| Vol 18, No 3 (2021) |
Prevalence and biomarkers in metabolic syndrome |
Abstract
PDF (Rus)
|
|
O. Y. Kytikova, M. V. Antonyuk, T. A. Kantur, T. P. Novgorodtseva, Y. K. Denisenko |
| |
| Vol 18, No 3 (2021) |
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the problem of conjunction and phasing |
Abstract
PDF (Rus)
|
|
E. V. Kiseleva, T. Y. Demidova |
| |
| Vol 18, No 3 (2021) |
Adipose tissue: colors, depots and functions |
Abstract
PDF (Rus)
|
|
T. I. Romantsova |
| |
| Vol 18, No 2 (2021) |
Resistance to drug treatment of acromegaly and ways to overcome it |
Abstract
PDF (Rus)
|
|
O. O. Golounina, L. K. Dzeranova, E. A. Pigarova, Zh. E. Belaya |
| |
| Vol 18, No 2 (2021) |
Risk Factors for Obesity Development in Different Periods of Childhood |
Abstract
PDF (Rus)
|
|
T. V. Chubarov, A. V. Bessonova, O. A. Zhdanova, A. A. Artyushchenko, O. G. Sharshova |
| |
| Vol 18, No 2 (2021) |
To the question of the pathogenetic mechanisms of the influence of obesity on the level of vitamin D |
Abstract
PDF (Rus)
|
|
L. A. Suplotova, V. A. Avdeeva, L. Y. Rozhinskaya |
| |
| Vol 18, No 2 (2021) |
Obesity is the basis of metabolic syndrome |
Abstract
PDF (Rus)
|
|
A. F. Verbovoy, N. I. Verbovaya, Yu. A. Dolgikh |
| |
| Vol 18, No 2 (2021) |
The influence of adiponectin on carbohydrates, lipids, and lipoproteins metabolism: analysis of signaling mechanisms |
Abstract
PDF (Rus)
PDF (Eng)
|
|
D. A. Tanyanskiy, A. D. Denisenko |
| |
| Vol 18, No 2 (2021) |
The importance of melatonin in the regulation of metabolism, eating behavior, sleep, and the prospects for the use of melatonin drugs for obesity treatment |
Abstract
PDF (Rus)
|
|
E. S. Tsvetkova, T. I. Romantsova, M. G. Poluektov, G. E. Runova, I. V. Glinkina, V. V. Fadeev |
| |
| Vol 18, No 2 (2021) |
Types of obesity and their impact on long-term outcomes in patients with cardiovascular disease |
Abstract
PDF (Rus)
|
|
S. V. Miklishanskaya, N. A. Mazur |
| |
| Vol 18, No 2 (2021) |
Obesity and functional bowel disorders: are they linked? |
Abstract
PDF (Rus)
|
|
A. V. Pogodina, A. I. Romanitsa, L. V. Rychkova |
| |
| Vol 18, No 3 (2021) |
Metabolic endotoxemia: possible causes and consequences |
Abstract
PDF (Rus)
|
|
V. A. Beloglazov, I. A. Yatskov, E. D. Kumelsky, V. V. Polovinkina |
| |
| 1 - 19 of 19 Items |
|
